All Press Releases for August 08, 2018

Shinichiro Akiyama Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who

Dr. Akiyama has been endorsed by Marquis Who's Who as a leader in the healthcare industry

He is in the process of launching a brand new cancer gene therapy product to cancer patients at a reasonable price.

    CHIBA, JAPAN, August 08, 2018 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Shinichiro Akiyama, MD, PhD, with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Akiyama celebrates many years of experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

With more than 20 years of professional experience, Dr. Akiyama has been the director of the R Future Cancer International Clinic since 2014, the board governor chief of the International Society of Personalized Medicine Integrative Oncology Section since 2011, and the secretary of the International Society of Integrative Medicine since 2010. In addition to his work in the field, he has held numerous teaching roles, including as a professor at Lan Zhou University Second Hospital since 2010 and as a visiting professor in the Department of Medical Oncology at McGill University since 2014.

From 2012 to 2014, Dr. Akiyama was the director of the UDX Hirahata Clinic, and from 2009 to 2012 he was the director of the Kudan Clinic Immune Cell Therapy Center. He served as executive vice president of Mitsukaido Sakura Hospital from 2007 to 2009, and as physician-in-chief in the Department of Internal Medicine at Saiyu Soka Hospital from 1998 to 2007. Earlier in his career, Dr. Akiyama was the medical chief of aerospace medicine with the National Space Development Agency of Japan from 1996 to 1998. He is in the process of launching a brand new cancer gene therapy product to cancer patients at a reasonable price.

Dr. Akiyama began his career as a student at Sapporo Medical University, earning a Doctor of Medicine in 1989. He joined Nikko Memorial Hospital as a resident in internal medicine until 1990, subsequently holding a second internal medicine residency with the Hakodate Red Cross Hospital from 1990 to 1992. From 1992 to 1996, he served in an oncology fellowship with the Sapporo Medical University Fourth Department of Internal Medicine. Later in his career, Dr. Akiyama earned a PhD from Showa University in 2005. In his free time, he enjoys karate, tennis, and astronomy.

In recognition of outstanding contributions to his profession and the Marquis Who's Who community, Dr. Shinichiro Akiyama has been featured on the Albert Nelson Marquis Lifetime Achievement website. Please visit for more information about this honor.

Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® now publishes many Who's Who titles, including Who's Who in America®, Who's Who in the World®, Who's Who in American Law®, Who's Who in Medicine and Healthcare®, Who's Who in Science and Engineering®, and Who's Who in Asia®. Marquis® publications may be visited at the official Marquis Who's Who® website at

# # #

Contact Information

Fred Marks
Marquis Who's Who Ventures LLC
Berkeley Heights, NJ
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: